Literature DB >> 2306556

Bone disease in children with homozygous beta-thalassemia.

L Rioja1, R Girot, M Garabédian, G Cournot-Witmer.   

Abstract

The histological features of thalassemic bone are imperfectly known, and the roles of bone marrow hyperactivity, iron overload or vitamin D deficiency in the pathogenesis of the disease are not clearly identified. In this study we examined iliac crest biopsies from 17 transfusion-dependent children with homozygous beta-thalassemia and severe radiological skeletal thalassemic changes, including widening of medullary spaces and osteoporosis. Rachitic lesions were not observed. Serum ferritin concentrations were increased in all but one subject. Iron deposits were histochemically detected in bone marrow, at the marrow-bone interface, along cement lines and mineralizing perimeters. Minor changes were present in trabecular bone, and osteomalacia was absent. By contrast, cortical bone exhibited severe changes including fissures and focal mineralization defects. Plasma 25-hydroxyvitamin D (25(OH)D) concentrations measured during the winter (December-May, 6.5 +/- 4.9 ng/ml, mean +/- SD, n = 6) and during the summer (June-November, 13.8 +/- 8.4 ng/ml, n = 9) did not differ from those of age-matched children living in the same country. Seven patients had moderate hypocalcemia but no biological signs suggestive of vitamin D deficiency: all had normal alkaline phosphatase activity, normal or slightly elevated plasma phosphate, only two had low plasma 25(OH)D concentrations and two others supranormal values of plasma immunoreactive parathyroid hormone. These results show that iron overload and vitamin D deficiency do not seem to play an important role in the pathogenesis of thalassemic bone disease, which is characterized by cortical lesions probably related to marrow hyperactivity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306556     DOI: 10.1016/0169-6009(91)90142-m

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  16 in total

1.  Case report 744. Deferoxamine-induced skeletal dysplasia.

Authors:  Z C Borenstein; C B Hyman; D L Rimoin; C L Chapman; R Lachman
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Growth plate injury of the long bones in treated beta-thalassemia.

Authors:  C Orzincolo; P N Scutellari; G Castaldi
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

3.  Impaired bone formation and osteopenia in heterozygous β(IVSII-654) knockin thalassemic mice.

Authors:  Kanogwun Thongchote; Saovaros Svasti; Mayurachat Sa-ardrit; Nateetip Krishnamra; Suthat Fucharoen; Narattaphol Charoenphandhu
Journal:  Histochem Cell Biol       Date:  2011-06-09       Impact factor: 4.304

4.  Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.

Authors:  Nicholas G Angelopoulos; Anastasia Goula; Grigorios Rombopoulos; Victoria Kaltzidou; Eugenia Katounda; Dimitrios Kaltsas; George Tolis
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.

Authors:  Rashid Merchant; Amish Udani; Vipla Puri; Valentina D'cruz; Deepak Patkar; Aarti Karkera
Journal:  Indian J Pediatr       Date:  2010-08-25       Impact factor: 1.967

6.  Endocrine and metabolic disorders in β-thalassemiamajor patients.

Authors:  Fatemeh Saffari; Abolfazl Mahyar; Shabnam Jalilolgadr
Journal:  Caspian J Intern Med       Date:  2012

7.  Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease.

Authors:  Edwin Patino; Stephen B Doty; Divya Bhatia; Kelly Meza; Yuan-Shan Zhu; Stefano Rivella; Mary E Choi; Oleh Akchurin
Journal:  Kidney Int       Date:  2020-06-20       Impact factor: 10.612

8.  Osteoporosis syndrome in thalassaemia major: an overview.

Authors:  Meropi Toumba; Nicos Skordis
Journal:  J Osteoporos       Date:  2010-05-26

Review 9.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

10.  Iron distribution in thalassemic bone by energy-loss spectroscopy and electron spectroscopic imaging.

Authors:  C Bordat; A Constans; O Bouet; I Blanc; C L Trubert; R Girot; G Cournot
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.